[1]
2007. Daily practice use of bortezomib in relapsed/refractory multiple myeloma: Safety/efficacy results of a compassionate use program in Switzerland. Swiss Medical Weekly. 137, 2122 (Jun. 2007), 317–322. DOI:https://doi.org/10.4414/smw.2007.11716.